Skip to main content
. Author manuscript; available in PMC: 2016 Apr 28.
Published in final edited form as: Radiother Oncol. 2016 Jan 9;118(1):85–91. doi: 10.1016/j.radonc.2015.11.035

Table 4.

Difference between groups during the 4-year follow-up.a

Radical Prostatectomy vs Brachytherapy Radical Prostatectomy vs IMRT Radical Prostatectomy vs Androgen Deprivationb

Domain Delta (95% CI) P Delta (95% CI) P Delta (95% CI) P
Urinary function −.12 (−2.52, 2.27) .9 3.18 (.54, 5.81) .019 −.85 (−6.00, 4.30) .7
 Incontinence 11.89 (8.15, 15.63) <.001 14.08 (9.81, 18.35) <.001 11.29 (2.69, 19.88) .010
 Irritation or obstruction −9.26 (−11.36, −7.16) <.001 −5.42 (−7.64, −3.19) <.001 −10.29 (−14.06, −6.52) <.001
Urinary bother 0.56 (−2.06, 3.18) .7 3.35 (0.42, 6.28) .025 −0.18 (−6.14, 5.78) 1
Bowel function −1.39 (−2.57, −0.21) .022 −1.42 (−2.74, −0.09) .036 0.33 (−1.76, 2.43) .8
 Pain or constipation −0.52 (−2.15, 1.11) .5 .80 (−1.18, 2.77) .4 1.92 (−1.63, 5.48) .3
 Diarrhea or frequency −1.74 (−3.25, −0.23) .024 −2.35 (−4.08, −.62) .008 −.01 (−2.74, 2.71) 1
 Rectal bleeding −1.37 (−3.19, .45) .14 −2.92 (−5.13, −.71) .010 −.96 (−4.21, 2.29) .6
Bowel bother −2.43 (−4.37, −0.50) .014 −3.05 (−5.16, −.93) .005 −2.19 (−5.29, .91) .2
Sexual function 17.45 (12.78, 22.11) <.001 13.51 (7.80, 19.23) <.001 3.75 (−6.19, 13.69) .5
 Sexual desire 10.66 (6.94, 14.39) <.001 5.56 (1.00, 10.13) .017 −2.43 (−10.35, 5.49) .5
 Erectile function 22.23 (16.36, 28.10) <.001 19.34 (12.14, 26.54) <.001 8·57 (−4.3, 21.17) .2
Sexual bother 11.94 (7.81, 16.07) <.001 11.19 (6.43, 15.96) <.001 3·11 (−5.66, 11.89) .5
 Intercourse bother 8.83 (4.53, 13.14) <.001 8.56 (3.65, 13.47) .001 3·42 (−5.69, 12.53) .5
 Intercourse satisfaction 17.02 (11.08, 22.96) <.001 14.84 (7.57, 22.10) <.001 2·19 (−10.30, 14.69) .7

Abbreviations: CI = confidence interval, IMRT = intensity-modulated radiotherapy.

a

Between means (delta) for area under the curve from 3 to 48 months in each domain and subdomain for the treatments specified, with 95% confidence intervals in parentheses. Radical prostatectomy (open or laparoscopic) is the reference group in all comparisons. A positive score means better function in radiotherapy compared to surgery.

b

The androgen-deprivation group includes radiotherapy patients (external beam or brachytherapy) who also received adjuvant or neoadjuvant hormones of any duration. Patients undergoing radiotherapy plus hormonal therapy are thus represented in both columns.